Long-term changes in management following n-of-1 trials of stimulants in attention-deficit/hyperactivity disorder C. Jane NiklesGeoffrey K. MitchellAlexandra Clavarino Clinical Trial 16 August 2007 Pages: 985 - 989
Effects of CYP2D6 polymorphisms on neuroleptic malignant syndrome Daiji KatoChiaki KawanishiYoshio Hirayasu Pharmacogenetics 14 August 2007 Pages: 991 - 996
Vitamin D receptor haplotypes protect against development of colorectal cancer Jana FlüggeSolveigh KrusekopfIvar Roots Pharmacogenetics 20 September 2007 Pages: 997 - 1005
Acute myocarditis after massive phenelzine overdose W. Stephen WaringWilliam A. H. Wallace Pharmacodynamics 07 September 2007 Pages: 1007 - 1009
Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT study Réginald HulhovenDominique RosillonArmel Stockis Pharmacodynamics 21 September 2007 Pages: 1011 - 1017
Population pharmacokinetic analysisof lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART Xavière PanhardMayeule Legrandthe Cophar 1 - ANRS 102 Study Group Pharmacokinetics and Disposition 11 August 2007 Pages: 1019 - 1029
Estimation of CYP2C19 activity by the omeprazole hydroxylation index at a single point in time after intravenous and oral administration Takenori NiiokaTsukasa UnoTomonori Tateishi Pharmacokinetics and Disposition 16 August 2007 Pages: 1031 - 1038
Evaluation of limited sampling strategies for tacrolimus Robert A. M. Op den BuijschAfke van de PlasOtto Bekers Pharmacokinetics and Disposition Open access 22 August 2007 Pages: 1039 - 1044
Pharmacokinetic–pharmacodynamic modeling of the miotic effects of dihydrocodeine in humans Helmut SchmidtJörn Lötsch Pharmacokinetics and Disposition 05 September 2007 Pages: 1045 - 1054
Persistence with antihypertensive treatments: results of a 3-year follow-up cohort study Joerg HasfordDetlef Schröder-BernhardiGerhard Dietlein Pharmacoepidemiology and Prescription 14 August 2007 Pages: 1055 - 1061
Attitudes toward psychiatric drug treatment: the experience of being treated Carlos De las CuevasEmilio J. Sanz Pharmacoepidemiology and Prescription 16 August 2007 Pages: 1063 - 1067
High concordance between self-reported medication and official prescription database information Jari HaukkaJaana SuvisaariJouko Lönnqvist Pharmacoepidemiology and Prescription 22 August 2007 Pages: 1069 - 1074
Recognition and management of potential drug–drug interactions in patients on internal medicine wards Priska VonbachAndré DubiedStephan Krähenbühl Pharmacoepidemiology and Prescription 06 September 2007 Pages: 1075 - 1083
Why healthy subjects volunteer for phase I studies and how they perceive their participation? Luis AlmeidaBenedita AzevedoPatrício Soares-da-Silva Pharmacoepidemiology and Prescription 20 September 2007 Pages: 1085 - 1094
Potential drug interactions during a three-decade study period: a cross-sectional study of a prescription register Emelie ÅstrandBengt ÅstrandGöran Petersson Erratum 25 September 2007 Pages: 1095 - 1095